Lisa McIntyre appointed to FPH’s Board

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Lisa McIntyre appointed to Fisher & Paykel Healthcare Board
Auckland, New Zealand, 24 August 2021 – Fisher & Paykel Healthcare Corporation Limited advises
that Lisa McIntyre, PhD, has been appointed as a non-executive director of the company with effect
from 1 October 2021.
“W e are pleas ed to annou nce Lisa’ s appointment and look forward to the insight she will bring to the
Board,” said Scott St John, Board Chair.
“Li sa has extensive knowledge in healt h and technology – with experience in strategy, finance,
technology transformation and data analytics. She has a deep understanding of international
markets and a reputation for insight, integrity and transparency.”
Dr McIntyre is an experienced company director with a broad portfolio that spans the health care,
insurance, technology and e-learning sectors. She is currently a non-executive director of Insurance
and Care NSW (a government public financial corporation), HCF Group (a private health insurance
company in Australia), The University of Sydney, Studiosity and Nanosonics, and chair of LEK
Consulting’s ANZ Advisory Board.
Prior to her director roles, Dr McIntyre spent 20 years as
a senior strategy partner with LEK
Consulting. She helped develop the company’s US biotechnology advisory practice from three
clients i n t he emerging sector to become t he largest biotechnology practice in t he US, providing
strategic, commercial and operational advice t o local and multinational companies in North America,
Asia and Australia.
The Fisher & Paykel Healthcare Board has determined that Dr McIntyre will be an independent
director of the Board. She will also serve as a member of the Quality, Safety and Regulatory
Committee, effective 1 October 2021.
A resolution to elect Dr McIntyre will be put t o shareholders at t he company’s next annual
shareholders’ meeting in August 2022. Dr McIntyre replaces Tony Carter, who retired from the
Board in August 2020.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems f or use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep
apnea. The company’s products are sol d in over 120 countries worldwide. For more information
about the company, visit our website www.fphcare.com.
ENDS
Media & Investor Contacts:
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 21 713 911
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073
Authorised by Fisher & Paykel Healthcare Corporation Limited’s Board Chair.